Two scientists working in a laboratory

Our Network

We’ve set the stage for innovation with our service partnerships, research collaborations, and industry affiliations.

Here’s what you need to know about the network that is saving you time, maximizing your budget, and delivering the best sequencing results.


  • Integrated DNA Technologies
  • 10x Genomics
  • Olink

Keeping an Eye on SARS-CoV-2

As an IDT AlignSM referred Sequencing Provider, IDT recognizes us as a cutting-edge and comprehensive sequencing provider. Together our companies share a commitment to collaborating and giving you access to cutting-edge technology and products.

IDT develops and manufactures nucleic acid products that support the life sciences industry.


➞ Read the News Release

Untitled design (7)

Looking Deeper into Biological Systems


Psomagen is a 10x Certified Service Provider (CSP) for the following single-cell sequencing (SCS) applications:


  • 3’ Gene Expression
  • 5’ Gene Expression
  • Immune Profiling
  • Multiome ATAC + Gene Expression
  • ATAC


This designation requires specialized training, evaluation, and yearly recertification, ensuring you receive the highest-standard SCS results.

10x Genomics is a life science technology company building products to help researchers interrogate, understand, and master biology.


➞ Read the Gene News Release

Services Enabled


Enabling Unprecedented Multiomics Research


Our partnership with Olink is giving scientists a more comprehensive view of human biology, enabling clinicians to predict disease and outcomes, and deliver patients a whole new level of precision medicine.


We offer the following Olink platforms:


  • Target 48/96
  • Explore 1536/3072

Olink Proteomics enables new discoveries across multiple disease areas with its innovative Proximity Extension Assay (PEA) using DNA coupled antibodies to identify and quantify protein biomarkers in clinical samples. 


➞ Read the News Release

Services Enabled


  • Integrated DNA Technologies
  • 10x Genomics
  • Olink


  • Variantyx
  • Fabric Genomics
  • Illumina

Enabling Personalized Medicine

Our collaboration with Variantyx helps you take patient samples from bench to bedside faster. 


We share your whole-genome sequencing (WGS) data directly with their team of bioinformaticians and software engineers, then deliver clinician-ready reports as an easy, one-stop solution.

Variantyx analyzes WGS data from a single patient sample, pulling out insight for a faster, more accurate diagnosis at a lower cost. 


→ Learn more in this podcast

Services Enabled



Speeding Up Rare Disease Diagnosis

Rare disease patients are getting a diagnosis faster because we work with Fabric Genomics to create clinical reports from next-generation sequencing (NGS) patient data.

Together our teams are improving lives and helping patients get the right care on an expedited timeline. 

Fabric Genomics offers a leading AI-based platform, NGS analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing.


→ Learn about our collaboration

Services Enabled



Supporting a Multiomics  Approach


We’ve been working with Illumina technology for nearly two decades.

Our collaboration with their team of experts and ongoing commitment to staying up to date mean you receive the high-quality and high-throughput scalability of Illumina’s platforms without investing in the equipment or the expertise yourself. 

Illumina Logo - copyright Illumina
  • Variantyx
  • Fabric Genomics
  • Illumina


  • Centers for Disease Control and Prevention SPHERES
  • COVID-19 Testing Industry Consortium

Keeping Up to Date on the COVID-19 Pandemic

SARS-CoV-2 Sequencing for Public Health Emergency Response, Epidemiology, and Surveillance (SPHERES) is an open genomics consortium established by the CDC’s Advanced Molecular Detection program in response to the COVID-19 pandemic.

Our participation keeps us up to date as new research and data changes our understanding of the disease, how it infects its hosts, and the best way to diagnose and treat patients.


Innovating Testing Through the Pandemic


The quality of COVID-19 testing is improved through the commitment and communication of members in the Bristol Myers Squibb COVID-19 Testing Industry Consortium.

We are proud to be one of 24 organizations participating in this important effort.

The consortium’s goal is to inform, improve, innovate, and accelerate various aspects of testing for COVID-19, ranging from research to clinical diagnostic applications.

  • Centers for Disease Control and Prevention SPHERES
  • COVID-19 Testing Industry Consortium
Three scientists working in NGS lab with Illumina NovaSeq and HiSeq instruments

Be Part of the Psomagen Network

We build relationships that make sense for our clients and their goals. If your organization can help deliver more innovative and insightful solutions to scientists, we want to hear about it.

Join Us